The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNPSN.L Regulatory News (NPSN)

  • There is currently no data for NPSN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Debt

13 Jan 2022 09:30

RNS Number : 3494Y
Prosus NV
13 January 2022
 

Prosus N.V.(Incorporated in the Netherlands)(Legal Entity Identifier: 635400Z5LQ5F9OLVT688)AEX and JSE Share Code: PRX ISIN: NL0013654783(Prosus)

 

PROSUS PRICES NEW 5-YEAR, 10-YEAR AND 30-YEAR TRANCHES USD BONDS AND 4-YEAR, 8-YEAR AND 12-YEAR TRANCHES EUR BONDS

On 11 and 12 January 2022, Prosus respectively priced USD and EUR notes in an aggregate principal amount totaling US$5.25 billion equivalent under its Global Medium-Term Note Programme. These issuances consist of US$1 billion 3.257% notes due 2027, US$1 billion 4.193% notes due 2032, US$1.25 billion 4.987% notes due 2052, €500 million 1.207% notes due 2026, €600 million 2.085% notes due 2030, and €650 million 2.778% notes due 2034 (the "Bonds").

The group has grown and diversified its business in the past couple of years, meaningfully increasing the size and value of its core segments of Classifieds, Food Delivery, Payments & Fintech and Edtech and thereby enhancing its credit profile. Over that same period, the group has considered it strategically important and financially prudent to make efficient use of the increased debt capacity built into our credit ratings. In line with our prudent liquidity management policy, the offerings will provide financial flexibility to pursue our growth initiatives both organically and through acquisitions, a strategy that has led to significant net asset value accretion for the group.

 

On 14 December 2021, Prosus's long-term rating was upgraded by S&P to BBB. It has a Baa3 rating from Moody's. It is expected that this financing will be ratings neutral.

 

The offerings are expected to close on 19 January 2022, in each case subject to customary closing conditions.

Application has been made to The Irish Stock Exchange plc trading as Euronext Dublin for the Bonds to be admitted to listing on the Official List and traded on the Global Exchange Market of Euronext Dublin.

Amsterdam, the Netherlands13 January 2022

JSE sponsor to ProsusInvestec Bank Limited

Investor Enquiries

Eoin Ryan, Head of Investor Relations

+1 347-210-4305investorrelations@prosus.com

Media Enquiries

Sarah Ryan, International Media Relations

+ 31 6 29721038sarah.ryan@prosus.com

 

Cautionary Statement

This announcement is for information purposes only and does not constitute a prospectus or any offer to sell or the solicitation of an offer to buy any security in the United States or in any other jurisdiction. Any securities mentioned herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or applicable state or foreign securities laws and may not be offered or sold in the United States absent registration under federal or applicable state securities laws or an applicable exemption from such registration requirements. Any securities mentioned herein have been and will only be offered (i) in the United States to investors who are reasonably believed to be both (1) qualified institutional buyers pursuant to Rule 144A under the Securities Act and (2) Qualified Purchasers (as defined in Section 2(a)(51)(a) of the U.S. Investment Company Act of 1940, as amended (the "Investment Company Act")), and the rules and regulations promulgated thereunder or (ii) outside the United States to investors who are both (1) non-U.S. residents (as defined for purposes of the Investment Company Act) and (2) non U.S. persons (within the meaning of Regulation S under the Securities Act).

This announcement contains information that qualifies, or may qualify, as inside information within the meaning of Article 7(1) of the Market Abuse Regulation (EU) 596/2014.

This announcement may include forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond Prosus's control and all of which are based on Prosus's current beliefs and expectations about future events. Forward-looking statements are sometimes identified by the use of forward-looking terminology such as "aim", "annualised", "anticipate", "assume", "believe", "continue", "could", "estimate", "expect", "forecast", "goal", "hope", "intend", "likely", "may", "objective", "plan", "position", "potential", "predict", "project", "risk", "seek", "should", "target", "will" or "would" or the highlights or the negatives thereof, other variations thereon or comparable terminology. These forward-looking statements include all matters that are not historical facts.

These forward-looking statements and other statements contained in this announcement regarding matters that are not historical facts involve predictions. No assurance can be given that such future results will be achieved; actual events or results may differ materially as a result of risks and uncertainties facing Prosus. Such risks and uncertainties could cause actual results to vary materially from the future results indicated, expressed or implied in such forward-looking statements.

Forward-looking statements in this announcement speak only as of the date they are made. Except as required by applicable laws and regulations, Prosus expressly disclaims any obligation or undertaking to update or revise the forward-looking statements contained in this announcement to reflect any change in its expectations or any change in events, conditions or circumstances on which such statements are based.

About Prosus

Prosus is a global consumer internet group and one of the largest technology investors in the world. Operating and investing globally in markets with long-term growth potential, Prosus builds leading consumer internet companies that empower people and enrich communities.

The group is focused on building meaningful businesses in the online classifieds, food delivery, payments and fintech, and education technology sectors in markets including India, Russia, and Brazil. Through its ventures team, Prosus invests in areas including health, logistics, blockchain, and social commerce. Prosus actively seeks new opportunities to partner with exceptional entrepreneurs who are using technology to improve people's everyday lives.

Every day, billions of customers use the products and services of companies that Prosus has invested in, acquired or built, including 99minutos, Aruna, AutoTrader, Autovit.ro, Avito, Azos, Bibit, Biome Makers, Borneo, Brainly, BUX, BYJU'S, Bykea, Captain Fresh, Codecademy, Collective Benefits, Creditas, DappRadar, DeHaat, Domofond.ru, dott, ElasticRun, eMAG, Endowus, Eruditus, EVERY, Facily, Flink, Good Glamm Group, GoodHabitz, Honor, iFood, Imovirtual, Klar, Kovi, LazyPay, letgo, Luno, Mensa Brands, Meesho, merXu, Movile, Oda, OLX, Otodom, OTOMOTO, PaySense, PayU, Pharmeasy, Properati, Property24, Quick Ride, Red Dot Payment, Republic, Shipper, ShopUp, SoloLearn, Stack Overflow, Standvirtual, Superside, Swiggy, Ula, Urban Company, and Wolt.

Hundreds of millions of people have made the platforms of Prosus's associates a part of their daily lives. For listed companies where we have an interest, please see: Tencent, Delivery Hero, Remitly, VK, Trip.com, Udemy, Skillsoft, Sinch and SimilarWeb.

Today, Prosus companies and associates help improve the lives of more than two billion people around the world.

Prosus has a primary listing on Euronext Amsterdam (AEX:PRX) and secondary listings on the Johannesburg Stock Exchange (XJSE:PRX) and a2X Markets (PRX.AJ). Prosus is majority-owned by Naspers.

For more information, please visit www.prosus.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODBKNBKCBKKKDD
Date   Source Headline
3rd Aug 201712:00 pmRNSCOMPETITION TRIBUNAL APPROVAL MEDIA24 NOVUS MERGER
2nd Aug 20172:00 pmRNSADR RATIO CHANGE
21st Jul 20173:11 pmRNSDirector/PDMR Shareholding
21st Jul 20171:00 pmRNSAnnual Financial Report
11th Jul 20174:56 pmRNSDirector/PDMR Shareholding
5th Jul 20174:50 pmRNSDirector/PDMR Shareholding
30th Jun 20177:30 amRNSBOND OFFERING BY MYRIAD - PRICING
23rd Jun 20172:00 pmRNSFinal Results
22nd Jun 20179:00 amRNSPOSSIBLE USD BOND OFFERING
14th Jun 20174:55 pmRNSTrading Statement
3rd Apr 201711:06 amRNSUPDATE ON MEDIA24 COMPETITION APPEAL COURT RULING
31st Mar 20173:29 pmRNSDirectorate Change
15th Mar 20172:06 pmRNSDirector/PDMR Shareholding
24th Feb 20172:30 pmRNSDirector/PDMR Shareholding
7th Feb 20172:21 pmRNSDirector/PDMR Shareholding
3rd Feb 20171:00 pmRNSNOTIFICATION s 122(3) OF THE CO ACT & s3.83(b) JSE
31st Jan 201712:00 pmRNSClosing of the ibibo/MakeMyTrip transaction
19th Jan 20172:01 pmRNSDirector/PDMR Shareholding
18th Jan 201711:30 amRNSClosing of the Allegro transaction
18th Jan 20177:14 amRNSNOTIFICATION IN TERMS OF S122(3) SA CO ACT
4th Jan 20172:30 pmRNSDirector/PDMR Shareholding
19th Dec 20163:00 pmRNSDirector/PDMR Shareholding
5th Dec 20163:30 pmRNSDirector/PDMR Shareholding
25th Nov 20162:00 pmRNSHalf-year Report
18th Nov 201612:20 pmRNSTrading Statement
18th Oct 20162:45 pmRNSMakeMyTrip Limited and Ibibo group to combine
14th Oct 20163:00 pmRNSDisposal
31st Aug 20164:30 pmRNSDirector/PDMR Shareholding
26th Aug 20164:00 pmRNSAGM Statement
22nd Jul 20162:30 pmRNSNotice of AGM
14th Jul 20164:09 pmRNSDirector/PDMR Shareholding
6th Jul 20164:01 pmRNSDirector/PDMR Shareholding
24th Jun 20165:00 pmRNSFinal Results
15th Jun 20162:00 pmRNSTrading Statement
13th Jun 20163:00 pmRNSNotice in terms of S122 of SA Companies Act
18th Apr 20164:00 pmRNSChange in reporting currency
31st Mar 20164:00 pmRNSDirector/PDMR Shareholding
31st Mar 20164:00 pmRNSDirector/PDMR Shareholding
15th Mar 20166:03 pmRNSADR ratio change and distribution
10th Mar 201612:31 pmRNSDirector/PDMR Shareholding
24th Feb 20163:12 pmRNSNOTIFICATION IN TERMS OF S122(3) OF THE CO ACT
29th Jan 20162:59 pmRNSDirectorate Change
26th Jan 20163:09 pmRNSDirector/PDMR Shareholding
26th Jan 201612:34 pmRNSDirector/PDMR Shareholding
20th Jan 20161:58 pmRNSCorrection to S122 notification just released
20th Jan 20161:36 pmRNSS122 of the SA Companies Act notification
30th Dec 20153:05 pmRNSDirector/PDMR Shareholding
29th Dec 20157:15 amRNSDirector/PDMR Shareholding
24th Dec 201510:05 amRNSDirector/PDMR Shareholding
18th Dec 20153:05 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.